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Background
High quality laboratory diagnosis is critical for any tuber-
culosis (TB) control program. Reliable and accurate
laboratory testing depends on collecting high quality speci-
mens, using careful collection methods, and properly stor-
ing and transporting specimens. Although various
guidelines for proper collection and handling exist in
Indonesia, there was no data on health worker compliance
with those guidelines. Such data could help the Ministry
of Health ensure staff capacity to carry out high quality
laboratory diagnosis.
Method
In September 2013, the USAID|DELIVER Project con-
ducted an assessment of specimen handling from collec-
tion to storage, transport, and handling at receiving sites.
The assessment also covered the availability of equipment
for the storage, packaging, and use of personal protective
equipment (PPEs); infectious waste handling; and the
availability of standard operating procedures (SOPs). The
National Tuberculosis Program (NTP) will use the results
to strengthen the TB program and build staff capacity.
Results
Packing of TB sputum specimens and transport to referral
sites is ongoing in the Drug Resistant TB project and in
other sentinel health centres in Indonesia. However, no
uniform standard operating procedures (SOPs) exist or are
enforced for the handling and transport of specimens.
Most collectors are not using cold chain with thermo-
meters in the shipment. Also, there are no measures to
protect the community and the environment during trans-
port of specimens, as required in United Nations/WHO
regulations. Many collection sites and receiving labora-
tories need additional cold chain equipment, especially
refrigerators, for specimen storage. Staff members need
basic training.
Discussion
Currently, there are no SOPs to protect the community
and environment during transport of TB specimens in
Indonesia. This includes the use of safe transport devices
and labels for infectious material or hazardous substances,
as required in UN/WHO regulations. Because the TB pro-
gram will most likely be expanded to sites far from the
current referral laboratories, more referral labs for cultures
and drug susceptibility testing (DST) should be prepared
and a more effective referral system developed. The MOH
also needs to establish uniform SOPs for the way equip-
ment/support devices are used by staff working on a vari-
ety of programs.
Lessons learned
The MOH should prioritize improving the country’s abil-
ity to perform TB cultures, including staff capability to
handle DST. SOPs should clearly state when, where and at
what temperature the cold chain is needed for sputum
and isolates. These new SOPs should be imparted to staff
and enforced.
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